RxDoctor Payments Data

Jenni Dorsey, PA

Physician Assistant · Brunswick, MDNPI 1467584219

Payments from drug & device makers

$5,439in general payments, 2019–2025

Across 227 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$1K
  • AbbVie$365
  • Boehringer Ingelheim$337
  • Amgen$296
  • Lilly USA, LLC$286
  • plus $946 from 20 others

What the payments were for

  • Food & beverage$5,439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,439 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$66,822
Medicare patients
284
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$63,908
JardianceEmpagliflozin13$18,584
Atorvastatin Calcium195$2,681
SynthroidLevothyroxine Sodium31$1,943
Duloxetine Hcl37$1,313
Bupropion XlBupropion Hcl29$983
Metformin Hcl ErMetformin Hcl76$935
Escitalopram Oxalate54$863
Pantoprazole Sodium34$826
Pravastatin Sodium42$755
Lisinopril97$725
Rosuvastatin Calcium56$640
Levothyroxine Sodium79$626
Metoprolol Succinate33$622
Gabapentin17$620

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,411$63,90839 claims
Boehringer IngelheimJardiance$337$18,58413 claims
AbbVieSynthroid$365$1,94331 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Brunswick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →